Cordoba Advisory Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$294K Buy
+242
New +$247K 0.06% 116
2026
Q1
Sell
-229
Closed -$247K 133
2025
Q4
$247K Buy
+229
New +$219K 0.06% 128

Other funds holding LLY

Cordoba Advisory Partners's LLY Position: Q2 2026 in Review

Cordoba Advisory Partners opened a new position in Eli Lilly (LLY) in Q2 2026: 242 shares worth $294K. The stake represents 0.06% of the portfolio and ranks #116 among its holdings. This is a return to the name: Cordoba Advisory Partners previously reported a position in LLY as recently as Q4 2025.

Cordoba Advisory Partners first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cordoba Advisory Partners held 242 shares of Eli Lilly worth $294K as of Q2 2026.
  • Eli Lilly was a new Cordoba Advisory Partners position in Q2 2026.
  • Eli Lilly made up 0.06% of Cordoba Advisory Partners's portfolio in Q2 2026, its #116 holding.
  • Cordoba Advisory Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cordoba Advisory Partners's 13F filing for Q2 2026, filed 21 Jul 2026.